Company Name, Ticker, Competitors, else..

Supernus Pharmaceuticals inc (SUPN)

Other Ticker:

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Supernus Pharmaceuticals inc

SUPN's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

SUPN Growth rates comparisons

Looking into Supernus Pharmaceuticals Inc growth rates, revenue grew by 5.2 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 1886

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -3.79 %

Supernus Pharmaceuticals Inc 's net income grew by 943.45 % in IV. Quarter 2022 year on year, above company average,

• More on SUPN's Growth

SUPN's Valuation comparisons

Supernus Pharmaceuticals Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Supernus Pharmaceuticals Inc realized cash outflow of $ -1.89per share in trailing twelve-month period.

Company

37.02

PE TTM

Industry

0.01

PE TTM

Company's Price to Sales ratio is at 3.13.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.47.

• More on SUPN's Valuation

Total Debt (Millions $)	402
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	4.22
Tangible Book Value (Per Share $)	1.14

SUPN's Valuation comparisons

Supernus Pharmaceuticals Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Supernus Pharmaceuticals Inc realized cash outflow of $ -1.89per share in trailing twelve-month period.

Company

37.02

PE TTM

Industry

0.01

PE TTM

Company's Price to Sales ratio is at 3.13.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 4.47.

Supernus Pharmaceuticals Inc Price to Book Ratio is at 2.36 higher than Indusry Avg. of 0.03, and higher than S&P 500 Avg. of -0.01

• More on SUPN's Valuation

• Market Capitalization (Millions $)	2,088
• Shares Outstanding (Millions)	58
• Employees	-
• Revenues (TTM) (Millions $)	667
• Net Income (TTM) (Millions $)	61
• Cash Flow (TTM) (Millions $)	-110
• Capital Exp. (TTM) (Millions $)	-
• Total Debt (Millions $)	402
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	4.22
• Tangible Book Value (Per Share $)	1.14

• Market Capitalization (Millions $)	2,088
• Shares Outstanding (Millions)	58
• Employees	-
• Revenues (TTM) (Millions $)	667
• Net Income (TTM) (Millions $)	61
• Cash Flow (TTM) (Millions $)	-110
• Capital Exp. (TTM) (Millions $)	-

SUPN's Profitability Comparisons
Supernus Pharmaceuticals Inc achieved increase in profitability, due to cost control. Operating Margin grew in IV. Quarter 2022 to 20.52 %. Supernus Pharmaceuticals Inc net profit margin of 15.23 % is currently ranking no. 36 in Major Pharmaceutical Preparations industry, ranking no. 78 in Healthcare sector and number 938 in S&P 500.

	*Ratio*
• Capital Ratio (MRQ)	1.37
• Total Debt to Equity (MRQ)	0.45
• Tangible Leverage Ratio (MRQ)	9.96
• Asset Turnover Ratio (TTM)	0.38
• Inventory Turnover Ratio (TTM)	1

SUPN's Profitability Comparisons

Supernus Pharmaceuticals Inc achieved increase in profitability, due to cost control. Operating Margin grew in IV. Quarter 2022 to 20.52 %.

Supernus Pharmaceuticals Inc net profit margin of 15.23 % is currently ranking no. 36 in Major Pharmaceutical Preparations industry, ranking no. 78 in Healthcare sector and number 938 in S&P 500.

• More on SUPN's Key Ratios


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar RLMD's Profile Stock Price RLMD's Financials Business Description Fundamentals Charts & Quotes RLMD's News Suppliers RLMD's Competitors Customers & Markets Economic Indicators RLMD's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071